Meanwhile, RNA-protein pull down assay found that Ago2, the core protein of RNA-induced silencing complexes (RISCs), could be abundantly detected in the products pulled down by LINC01152 biotin-probe (Fig. 3D), which proved the ceRNA potential of LINC01152 in GBM. The gene discussed is AGO2; the disease is glioblastoma.